Balasa Dinverno & Foltz’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$324K Sell
8,840
-250
-3% -$11.1K 0.02% 260
2022
Q2
$387K Sell
9,090
-50
-0.5% -$2.38K 0.02% 231
2022
Q1
$491K Sell
9,140
-690
-7% -$40.2K 0.03% 195
2021
Q4
$707K Sell
9,830
-380
-4% -$23.8K 0.05% 166
2021
Q3
$581K Sell
10,210
-70
-0.7% -$4.26K 0.04% 179
2021
Q2
$669K Buy
10,280
+10
+0.1% +$631 0.05% 158
2021
Q1
$611K Buy
10,270
+220
+2% +$12K 0.05% 159
2020
Q4
$475K Sell
10,050
-530
-5% -$22.3K 0.04% 171
2020
Q3
$351K Sell
10,580
-160
-1% -$5.51K 0.03% 191
2020
Q2
$347K Sell
10,740
-1,080
-9% -$29.5K 0.04% 160
2020
Q1
$284K Buy
+11,820
New +$340K 0.04% 193

Other funds holding LRCX

Balasa Dinverno & Foltz's LRCX Position: Q3 2022 in Review

Balasa Dinverno & Foltz reduced its Lam Research (LRCX) stake by 2.8% in Q3 2022, selling an estimated $11.1K and leaving 8,840 shares worth $324K. The position accounts for 0.02% of the portfolio, ranked #260.

Balasa Dinverno & Foltz first reported a position in LRCX in Q1 2020 and has held it in 11 quarters since. The position peaked at $707K in Q4 2021. 1,271 funds tracked by Wall St. Rank hold LRCX as of Q3 2022.

  • Balasa Dinverno & Foltz held 8,840 shares of Lam Research worth $324K as of Q3 2022.
  • Balasa Dinverno & Foltz sold 250 Lam Research shares in Q3 2022, an estimated $11.1K.
  • Lam Research made up 0.02% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #260 holding.
  • Balasa Dinverno & Foltz first reported a position in Lam Research in Q1 2020 and has held it in 11 quarters since.
  • Balasa Dinverno & Foltz's Lam Research position peaked at $707K in Q4 2021.
  • 1,271 funds tracked by Wall St. Rank held Lam Research as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.